Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 18/20 | 0.63 |
| ▸ | FNTB | P49356 | 18/20 | 0.63 |
| ▸ | PGGT1B | P53609 | 11/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7047035 | 0.78 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL7047031 | 0.77 | FNTA (0.65) | FNTAFNTBPGGT1B | |
| SCHEMBL7050845 | 0.75 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL7049991 | 0.74 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL7047026 | 0.74 | FNTA (0.54) | FNTAFNTBPGGT1B | |
| SCHEMBL7051608 | 0.72 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL7048886 | 0.69 | FNTA (1.00) | FNTAFNTBPGGT1B | |
| SCHEMBL7047915 | 0.68 | FNTA (0.48) | FNTAFNTBPGGT1BRAB9A | |
| SCHEMBL7053273 | 0.68 | FNTA (0.49) | FNTAFNTBPGGT1B | |
| SCHEMBL7046920 | 0.67 | FNTA (0.73) | FNTAFNTBPGGT1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030216441-A1 | Farnesyltransferase inhibitors | WEINSTOCK, STEVEN F. | 2003-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216441-A1 | Farnesyltransferase inhibitors | FNTA, FNTB, LCAT | FNTA 1/4885FNTB 2/4885PGGT1B 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.